Acton, et al., "Improved Antitumor Effects in 3'-Branched Homologues of 2'-Deoxythioguanosine. Synthesis and Evaluation of Thioguanine Nucleosides of 2,3-Dideoxy-3-(hydroxymethyl)-D-erythro-pentofuranose," J. Med. Chem. 22:518-525 (1979). |
Ayoola, et al., "Progress in the Control of Viral Hepatitis. Memorandum from a WHO Meeting," Bulletin of the World Health Organization, 66(4):443-455 (1988). |
Balzarini, J., et al., "Potent and Selective Anti-HTLV-III/LAV Activity of 2',3'-Dideoxycytidinene . . . , " Bioch. and Bioph. Res. Comm. 140(2):735-742 (1986). |
Bamford, et al., "Synthesis and Antiviral Activity of 3'-Deoxy-3'-C-hydroxymethyl Nucleosides," J. Med. Chem., 33:2494-2501 (1990). |
Beach, J.W., et al., "Synthesis of EnantiomericallyPure (2'R,5'S)-(-)-1-�2-(hydroxymethyl)-oathiolan-5-yl!Cytosine . . . ," J. Org. Chem. 57:2217-2219 (1992). |
Beasley, et al., "Hepatocellular Carcinoma and Hepatitis B Virus," The Lancet, 1129-1133 (1981). |
Belleau, B., et al., "Design and Activity of a Novel Class of Nucleoside Analogs . . . ," Intl. Conf. on AIDS, Montreal, Quebec, Canada, Jun. 4-9, 1989. |
Borthwick, D.A., et al., "Synthesis and Enzymatic Resolution of Carbocyclic 2'-Ara-Fluoro-Guanosine: A Potent New Anti-Herpetic Agent," J. Chem. Soc. Commun., 10:656-658 (1988). |
Boutelje, et al., Chemical Abstracts 108:128048 (1987). |
Carter, et al., "Activities of (-)-Carbovir and 3'-Azido-3'-Deoxythymidine Against Human Immunodeficiency Virus In Vitro," Antimicorbial Agents and Chemotherapy, 34(6):1297-1300 (1990). |
Chang, C.-N., et al., "Biochemical Pharmacology of (+) and (-)-2',3'-Dideoxy-3'Thioacytidine as Anti-Hepatatis B Virus Agents," J. Biol. Chem. 267(31):22414-22420 (1992). |
Chang, Chien-Neng, et al., "Deoxycytidine Deaminase-resistant Steroisomer is the Active Form of (+)-2',3'-Thiacytidine in the Inhibition of Hepatitis B Virus Replication," J. Bio. Chem., 267(20):13938-13942 (1992). |
Chang, Chungming, et al., "Production of Hepatitis B Virus in vitro by Transient Expression . . ., " The EMBO J. 6(3):675-680 (1987). |
Chen, Chin-Ho, et al., "Delayed Cytotoxicity and Selective Loss of Mitochondrial DNA in Cells . . . ," J. Bio. Chem. 264(20):11934-11937 (1989). |
Cheng, Y.C., et al., "Human Deoxycytidine Kinase Purification and Characterization . . ., " Biochim. Biophys. Acta. 481:481-492 (1977). |
Cheng, et al., J. Biol. Chem., 262:2187 (1987). |
Chu, et al., "Structure-Activity Relationships of Pyrimide Nucleosides as Antiviral Agents for Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells," J. Med. Chem., 32:612 (1989). |
Chu, et al., "Enantiomeric Synthesis of (+)-BCH-189�(+)-(2S,5R)-1-�2-(Hydroxymethyl)-1,3-oxathiolane-5-yl!cytosine! from D-Mannose and Its Anti-HIV Activity," J. Org. Chem., 56:6503-6505 (1991). |
Chu, C.K., et al., "An Efficient Total Synthesis of 3'-Azido-3'-Deoxythimidine (AZT) and 3'-Azido-2',3'-Dideoxyuridine (AZDDU, CS-87) from D-Mannitol," Tetrahedron Lett, 29(42):5349-5352 (1988). |
Chu, et al., "Comparative Activity of 2',3'-Saturated and Unsaturated Pyrimidine and Purine Nucelosides . . . , " Biochem. Pharm. 37(19):3543-3548 (1988). |
Chu, et al., "Structure-Activity Relationships of Pyrimidine Nucleosides as Antiviral Agents . . . , " J. Med. Chem. 32:612-617 (1989). |
Chu, C.K., et al., "2'-Fluoro-5-Methyl.beta.-L-Arabinofuranocyluracil as a Novel Antiviral Agent for Hepatitis B . . . , " Antimicrob. Agents Chemother., 39(4):979-981 (1995). |
Chu, et al., "Synthesis and Biological Evaluation of D-(2S) and L-(2R)-1,3-Oxathiolanyl-and D-(2R)-and L-(2S)-1,3-Dioxolanyl-Nucleosides as Anti-HIV and Anti-HBV Agents,"0 Antiviral Research, 30(S1):192 (Apr. 1993). |
Chu, et al., "Synthesis and Anti-HIV and Anti-HBV Activity of Enantiomerically Pure Oxathiolane Nucleosides," Antiviral Research, 17(S1):2 (Mar. 1992). |
Chu, et al., "Asymmetric Synthesis of Enantiomerically Pure (-)-(1'R,4'R)-Dioxolane-thymine and Its Anti-HIV Activity," Tetrahedron Letters, 32(31):3791-3794 (1991). |
Coates, J., et al., "The Separated Enaniomers of 2'-deoxy-3'-thiacytidine (BCH-189) Both Inhibit Human Immunodeficiency Virus Replication In Vitro," Antimicrob. Agents Chemother. 36(1):202-205 (1992). |
Condreay, et al., "Evaluation of the Potent Anti-Hepatitis B Virus Agent (-) cis-5-Fluoro-1-�2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl!Cytosine in a Novel In Vivo Model," Antimicrobial Agents and Chemotherapy, 616-619 (1992). |
Cretton, E., et al., "Catabolism of 3'-Azido-3'-Deoxythymidine in Heptaocytes and Liver Microsomes, with Evidence of Formation of 3'Amino-3'-Deoxythymidine a Highly Toxic Catabolite for Human Bone Marrow Cells," Molecular Pharmacology, 39:258-266 (1991). |
Cretton, E., et al., "Pharmokinetics of 3'-Azido-3'-Dexoythymidine and its Catabolites and Interactions with Probenecid in Rhesus Monkeys," Antimicrobial Agents and Chemotherapy, 35(5):801-807 (1991). |
Di Bisceglie, Adrian M. Rustgi, Vinod K. et al., "Hepatocellular Carcinoma," NIH Conference, Annals of Internal Medicine, 108:390-401 (1988). |
Doong, Shin-Lian, et al., "Inhibition of the Replication of Heptitis B virus in vitro by 2',3'-Dideoxy-3'-Thiacytidine and Related Analogues," Natl. Acad. Sci. USA, 88:8495-8499 (1991). |
Eriksson, et al. Antimicrobial Agents and Chemotherapy, 33(10):1729-1734 (1988). |
Frick, et al., "Pharmacokinetics, Oral Bioavailability, and Metabolic Disposition in Rats of (-)-cis-5-Fluoro-1�2-(Hydroxymethyl)-1,3-Oxzathiolan-5-yl!Cytosine, a Nucleoside Analog Active against Human Immunodeficiency Virus and Hepatitis B Virus," Antimicrobial Agents and Chemotherapy, 37(11):2285-2292 (1993). |
Furman, et al., "The Anti-Hepatitis B Virus Activities, Cytotoxicities, and Anabolic Profiles of the (-) and (+) Enantiomers of cis-5-Fluoro-1-�2-(Hydromethyl)-1,3-Oxathiolane-5-yl)! Cytosine," Antim. Agents and Chemo., 36(12):2686-2692 (1992). |
Furman, et al., Proc. Natl. Acad. Sci. U.S.A., 83:3333 (1986). |
Ganem, "Animal Models of Hepatitis B Virus," Experimental Models in Antimicrobial Chemotherapy, 2:259-272 (1986). |
Ganem, Don et al., "The Molecular Biology of the Hepatitis B Viruses," Ann. Rev. Biochem. 56:651-693 (1987). |
Gerlt, Chemical Abstracts, 107:14979 (1987). |
Hamamoto, et al., Antimicrobl. Agents. Chemother., 31:907 (1987). |
Herdewign, P. et al., "Resolution of Aristeromycin Enantiomers," J. Med. Chem., 28:1385-1386 (1985). |
Hoong, et al., "Enzyme-Mediated Enantioselective Preparation of Pure Enantiomers of the Antiviral Agent 2',3'-Dideoxy-5-Fluoro-3'-Thiacytidine (FTC) and Related Compounds," J. of Org. Chem., 57:5563-5565 (1992). |
Jeong, L., et al., "Asymmetric Synthesis and Biological Evaluation of .beta.-L-(2R,5S)-and a-L-(2R-5R)-1,3-Oxathiolane-Pyrimidine and -Purine Nucleotsides and Potential Anti-HIV Agents," J. Med. Chem., 36(2):181-195 (1993). |
Jeong, et al., "An Efficient Synthesis of Enantiomerically Pure (+)-(2S,5R)-1-�2-(Hydroxymethyl)-1,-oxathiolan-5-y;!cytosine �(+)-BCH-189! from D-Galactose," Tetrahedron Letters, 33(5):595-598 (1992). |
Jones and Bischofberger, "Minireview: nucleotide prodrugs," Antiviral Research, 27:1-17 (1995). |
Jurovcik and Holy, "Metabolism of pyrimidine L-nucleosides," Nucleic Acid Research, 3(8):2143-2154 (1976). |
Kassianides, Chris, et al., "Inhibition of Duck Hepatitis B Virus Replication by 2',3'-Dideoxycytidine," Gastroenterology, 97(5):1275-1280 (1989). |
Kim, H.O., et al., "Potent Anti-HIV and Anti-HBV Activities of (-)-L-.beta.-Dioxolane-C and (+)-L-.beta.-Dioxolane-T and Their Asymmetric Syntheses," Tetrahedron Lett, 33(46):6899-6902 (1992). |
Kim, H.O., et al., "L-.beta.-(2S,4S)-and L-.alpha.-(2S,4R)-Dioxolanyl Nucleosides as Potential Anti-HIV Agents: Asymmetric Synthesis and Structure-Activity Relationships," J. Med. Chem., 36(5):519-528 (1993). |
Kim, et al., "L-.beta.-(2S,4S)-and L-.alpha.-(2S,4R)-Dioxolanyl Nucleosides as Potential Anti-HIV Agents: Asymmetric Synthesis and Structure-Activity Relationships," J. of Med. Chem., 36(5):519-528 (1993). |
Krenitsky, T.A. et al., "An Enzymatic Synthesis of Purine D-arabinonucleosides," Carbohydrate Research, 97:139-146 (1981). |
Lee, Bonita, et al., "In Vitro and In Vivo Comparison of the Abilities of Purine and Pyrimidine 2',3'-Dideoxynucleosides To Inhibit Duck Hepadnavirus," Antimicrobial Agents and Chemotherapy, 33(3):336-339 (1989). |
Lin, et al., "Potent and Selective In Vitro Activity of 3'-Deoxythminidine-2-Ene-(3'-Deoxy-2',3'-Didehydrothymidine) Against Human Immunodeficiency Virus," Biochem. Pharm., 36(17):2716 (1987). |
Mahmoudian, M., et al., "Enzymatic Production of Optically Pure (2'R-cis)-2;-deoxy-3'-tiacytidine (3TC, Lamivudine): A Potent Anti-HIV Agent," published by the Glaxo Group Research Ltd., Enzyme Microbl. Technol., 15:749-755 (1993). |
Martin, et al., J. Med. Chem., 33:2137 (1990). |
Matthes, E., et al., "Potent Inhibition of Hepatitis B Virus Production In Vitro by Modified . . . ," Anti. Agents and Chemot, 34(10):1986-1990 (1990). |
Miller, Roger H., et al., "Common Evolutionary Origin of Hepatitis B Virus and Retroviruses," Proc. Natl. Acad. Sci. USA, 83:2531-2535 (1986). |
Mitsuya, H., et al., "3'-Azido-3'-Deoxythymidine (BW A 509U): An Antiviral Agent that Inhibits and Infectivity and Cytopathic Effect of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus In Vitro," Proc. Natl. Acad. Sci., USA 82:7097-7100 (1985). |
Mitsuya, H., et al., "Rapid in Vitro Systems for Assessing . . . , " AIDS: Modern Concepts and Therapeutic Challenges, S. Broder, Ed. p. 303, Marcel-Dekker, New York (1987). |
Mitsuya, H., et al., "Molecular Targets for AIDS Therapy," Science, 249:1533-1544 (1990). |
Norbeck, D., et al. "A New 2',3'-Dideoxynucleoside Prototype with In Vitro Activity Against HIV," Tetrahedron Lett, pp. 6263-6266 (1989). |
Norin, Chemical Abstracts, 108:146380 (1987). |
Ohno, et al., Chemocal Abstracts, 112:194612 (1989). |
Okabe, M., et al., "Synthesis of the Dideoxynucleosides ddC and CNT . . . ," J. Org. Chem., 53(20):4780-4786 (1988). |
Pai, S.b., et al., "Inhibition of Hepatitis B Virus by a Novel L-Nucleoside, 2'-Fluoro-5-Methyl-.beta.-L-Arabinofuranosyl Uracil," Antimicrobial Agents and Chemotheraphy, 40(2):380-386 (1996). |
Paff, et al., "Intracellular Metabolism of (-)-and (+)-cis-5-Fluoro-1-�2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl!Cytosine in HepG2 Derivative 2.2.15 (Subclone P5A) Cells," Antimicrobial Agents and Chemotherapy, 1230-1238 (1994). |
Richman, D. D., et al., "The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS . . . , " N. Eng. J. Med., 317(4):192-197 (1987). |
Saari, et al., "Synthesis and Evaluation of 2-Pyridinone Derivatives as HIV-1-Specific Reverse Transcriptase Inhibitors. 2. Analogues of 3-Aminopyridin-2(1H)-one," J. Med. Chem., 35:3792-3802 (1992). |
Satsumabayashi, S. et al., "The Synthesis of 1,3-Oxathiolane-5-one Derivatives," Bull. Chem. Soc. Japan, 45:913-915 (1972). |
Schinazi, et al., "Pure Nucleoside Enantiomers of .beta.-2',3'-Dideoxycytidine Analogs are Selective Inhibitors of Hepatitis B Virus In Vitro," Antimicrobial Agents and Chemotherapy, 38(9):2172-2174 (1994). |
Schinazi, R.F., et al., "Selective Inhibition of Human Immunodeficiency Viruses by Racemates and Enantiomers of cis-5-Fluoro-1-2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl) Cytosine," Antim. Agents and Chemo., 36(11):2423-2431 (1992). |
Schinazi, R.F., et al., "Rapid Communications: Substrate Specificity of Escherichia Coli. Thymidine Phosphorylase for Pyrimidine Nucleoside with an Anti-Human Immunodeficiency Virus Activity," Bioch. Pharm., 44(2):199-204 (1992)*. |
Schinazi, R.F., et al., "Activities of the Four Optical Isomers of 2'3'-Dideoxy-3'-Thiacytidine . . . ," Antimic. Agents & Chemo., 36(3):672-676 (1992)*. |
Schinazi, R.F., et al., "Insights into HIV Chemotherapy," AIDS Research and Human Retroviruses 8(6):963-989 (1992). |
Schinazi, R.F., et al., "Pharmacokinetics and Metabolism of Racemic 2',3'-Dideoxy-5 . . . ," Antimicrobial Agents and Chemotherapy 36(11):2432-2438 (1992). |
Schinazi, et al., Antimicrob. Agents Chemother., 33:115 (1989). |
Secrist, J.A., et al., "Resolution of Racemic Carbocyclic Analogues of Purine Nucleosides Through the Action of Adenosine Deaminase Antiviral Activity of the Carbocyclic 2'-Deoxyguanosine," J. Med. chem., 30:746-749 (1987). |
Sells, Mary Ann, et al, "Production of Hepatitis B Virus Particles in Hep G2 Cells . . . , " Proc. Natl. Acad. Sci. USA, 84:1005-1009 (1987). |
Shuto, et al., "Phospholipase D-Catalyzed Trans-Alkylphosphorylation; A Facile One-Step Synthesis of Nucleoside 5'-Alkylphosphates," Chem. Pharm. Bull., 36:5020 (1988). |
Soudeyns, H., et al., "Anti-Human Immunodeficiency Virus Type 1 Activity and In Vitro Toxicity of 2'-Deoxy-3'-Thiacytidine . . ., " Antimicrobial Agents and Chemotherapy, 35(7):1386-1390 (1991). |
Spadari, S., et al., "L-Thymidine Is Phosphorylated by Herpes Simplex Virus Type 1 . . . , " J. Med. Chem., 35(22):4214-4220 (1992). |
St. Clair et al., Antimicrob. Agents Chemother., 31:1972 (1987). |
Sterzycki, R.Z., et al., "Synthesis and Anti-HIV Activity of Several 2'-Fluoro-Containing Pyrimidine Nucelosides," J. Med. Chem., 33(8):2150-2157 (1990). |
Storer, R., et al., "The Resolution and Absolute Stereochemistry of the enantiomeris of cis-1-2-(Hydromethyl)-1,3-Oxathiolan-5-yl)cytosine (BCH-189); Equipotent Anti-HIV Agents," Nucleosides & Nucleotides, 12(2):225-236 (1993). |
Van Roey, et al., J. Am. Chem. Soc., 110:2277 (1988). |
Van Roey, et al., Proc. Natl. Acad. Sci. USA, 86:3929 (1989). |
Volk, Wesley A., editor, "Hepatitis," Essentials of Medical Microbiology, J.B. Lippincott Company, (Philadelphia/Toronto), 2nd Ed., pp. 609-618 (1982). |
Vorbruggen, et al., "Nucleoside Synthesis with Trimethylsilyl Triflate and Perchlorate as Catalysts," Chem. Ber., 114:1234-1255 (1981). |
Watanabe, et al., J. Med. Chem., 33:2145 (1990). |
Wilson, L.J., et al., "The Synthesis and Anti-HIV Activity of Pyrimidine Dioxolanyl Nucleosides," Bioorganic & Medicinal Chemistry Letters, 3(2):169-174 (1993). |
Wilson, L.J., et al., "A General Method for Controlling Glycosylation Stereochemistry in the Synthesis . . ., " Tetrahedron Lett, 31(13):1815-1818 (1990). |
Yarchoan, et al., Science, 245:412 (1989). |
Yokota et al., "Comparative Activities of Several Nucleoside Analogs Against Duck . . . , " Antimicrobial Agents and Chemotherapy, 34(7):1326-1330 (1990). |
Zhu, Zhou, et al., "Cellular Metabolism of 3'-Azido-2',3'-Dideoxyuridine with Formation of 5'-O-Diphophoshexase . . . " Molecular Pharmacology, 38:929-938 (1990). |